FI60870C - Foerfarande foer framstaellning av farmakologiskt vaerdefulla o-substituerade 7beta-amino-3-cefem-3-ol-4-karbonsyrafoereningar - Google Patents

Foerfarande foer framstaellning av farmakologiskt vaerdefulla o-substituerade 7beta-amino-3-cefem-3-ol-4-karbonsyrafoereningar Download PDF

Info

Publication number
FI60870C
FI60870C FI1752/73A FI175273A FI60870C FI 60870 C FI60870 C FI 60870C FI 1752/73 A FI1752/73 A FI 1752/73A FI 175273 A FI175273 A FI 175273A FI 60870 C FI60870 C FI 60870C
Authority
FI
Finland
Prior art keywords
cephem
formula
compounds
carboxylic acid
amino
Prior art date
Application number
FI1752/73A
Other languages
English (en)
Finnish (fi)
Other versions
FI60870B (fi
Inventor
Riccardo Scartazzini
Hans Bickel
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH978872A external-priority patent/CH587268A5/de
Priority claimed from CH1872272A external-priority patent/CH605987A5/de
Priority claimed from CH265573A external-priority patent/CH605988A5/de
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI60870B publication Critical patent/FI60870B/fi
Application granted granted Critical
Publication of FI60870C publication Critical patent/FI60870C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/59Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with hetero atoms directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65613Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. cephalosporins and analogs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI1752/73A 1972-06-29 1973-05-30 Foerfarande foer framstaellning av farmakologiskt vaerdefulla o-substituerade 7beta-amino-3-cefem-3-ol-4-karbonsyrafoereningar FI60870C (fi)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
CH978872A CH587268A5 (en) 1972-06-29 1972-06-29 Substd carboxylic acid derivs - broad spectrum antibiotics and inters
CH978872 1972-06-29
CH1219572 1972-08-17
CH1219572 1972-08-17
CH1872272A CH605987A5 (en) 1972-12-22 1972-12-22 Substd carboxylic acid derivs
CH1872272 1972-12-22
CH265573A CH605988A5 (en) 1973-02-23 1973-02-23 Substd 7-beta-amino ceph-3-em-3-ol 4-carboxylic acids
CH265573 1973-02-23

Publications (2)

Publication Number Publication Date
FI60870B FI60870B (fi) 1981-12-31
FI60870C true FI60870C (fi) 1982-04-13

Family

ID=27428472

Family Applications (3)

Application Number Title Priority Date Filing Date
FI1752/73A FI60870C (fi) 1972-06-29 1973-05-30 Foerfarande foer framstaellning av farmakologiskt vaerdefulla o-substituerade 7beta-amino-3-cefem-3-ol-4-karbonsyrafoereningar
FI1750/73A FI59601C (fi) 1972-06-29 1973-05-30 Foerfarande foer framstaellning av farmakologiskt vaerdefulla 0-substituerade 7beta-amino-3-cefem-3-ol-4-karbonsyrafoereningar
FI1751/73A FI59602C (fi) 1972-06-29 1973-05-30 Foerfarande foer framstaellning av farmakologiskt vaerdefulla 0-substituerade 7beta-amino-3-cefem-3-ol-4-karbonsyrafoereningar

Family Applications After (2)

Application Number Title Priority Date Filing Date
FI1750/73A FI59601C (fi) 1972-06-29 1973-05-30 Foerfarande foer framstaellning av farmakologiskt vaerdefulla 0-substituerade 7beta-amino-3-cefem-3-ol-4-karbonsyrafoereningar
FI1751/73A FI59602C (fi) 1972-06-29 1973-05-30 Foerfarande foer framstaellning av farmakologiskt vaerdefulla 0-substituerade 7beta-amino-3-cefem-3-ol-4-karbonsyrafoereningar

Country Status (26)

Country Link
US (2) US4073902A (xx)
JP (3) JPS5933598B2 (xx)
AR (6) AR206201A1 (xx)
AT (5) AT356809B (xx)
BE (1) BE801597A (xx)
BG (1) BG24954A3 (xx)
CA (1) CA1110230A (xx)
DD (3) DD106184A5 (xx)
DE (1) DE2331133C2 (xx)
DK (1) DK153324B (xx)
FI (3) FI60870C (xx)
FR (1) FR2190418B1 (xx)
GB (1) GB1435111A (xx)
HK (1) HK73778A (xx)
HU (3) HU167726B (xx)
IE (1) IE37767B1 (xx)
IL (1) IL42506A (xx)
LU (3) LU67888A1 (xx)
MY (1) MY7900008A (xx)
NL (3) NL7309136A (xx)
NO (3) NO145241C (xx)
PH (1) PH18567A (xx)
PL (1) PL91608B1 (xx)
RO (4) RO64419A (xx)
SE (5) SE417429B (xx)
YU (8) YU39910B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU36970B (en) * 1973-02-23 1984-08-31 Lilly Co Eli Process for obtaining 7-(amino)-acylamido-3-halocephalosporins
AU498131B2 (en) * 1974-02-26 1979-02-15 Ciba-Geigy Ag Production of cephems by cyclization
US4301278A (en) * 1974-02-26 1981-11-17 Ciba-Geigy Corporation Process for the manufacture of enol derivatives
US3928334A (en) * 1974-06-06 1975-12-23 Bristol Myers Co Process for the production of cefamandole
US4045435A (en) * 1974-10-09 1977-08-30 Eli Lilly And Company Preparation of cephalosporin ethers
AT342197B (de) * 1975-02-20 1978-03-28 Ciba Geigy Ag Neues verfahren zur herstellung von 3-cephemverbindungen
US4147864A (en) * 1975-02-20 1979-04-03 Ciba-Geigy Corporation Process for the manufacture of 7β-amino-3-cephem-3-ol-4 carboxylic acid compounds
CH622802A5 (xx) * 1975-08-20 1981-04-30 Ciba Geigy Ag
PH17188A (en) * 1977-03-14 1984-06-14 Fujisawa Pharmaceutical Co New cephem and cepham compounds and their pharmaceutical compositions and method of use
US4604386A (en) * 1984-07-09 1986-08-05 Eli Lilly And Company 3-(alkynylalkyloxy) cephalosporins
CA1274832A (en) 1985-04-30 1990-10-02 Richard Elmer Holmes 7-substituted bicyclic pyrazolidinones
JP2676763B2 (ja) * 1987-02-27 1997-11-17 萬有製薬株式会社 セファロスポリン誘導体
ATE111468T1 (de) * 1987-02-27 1994-09-15 Banyu Pharma Co Ltd Cephalosporinderivate, verfahren zu ihrer herstellung und antibakterielle mittel.
JPS63255800A (ja) * 1987-04-14 1988-10-24 礒井 誠二郎 警報装置
AU618029B2 (en) * 1987-11-02 1991-12-12 Imperial Chemical Industries Plc Polypeptide compounds
GB8813356D0 (en) * 1988-06-06 1988-07-13 Ici Plc Polypeptide compounds
ATE143355T1 (de) 1991-07-03 1996-10-15 Ciba Geigy Ag Pharmakologisch wirksame hydrazinderivate und verfahren zu deren herstellung
GB9115203D0 (en) * 1991-07-15 1991-08-28 Biochemie Gmbh Improvements in or relating to beta lactam production
ES2215628T5 (es) * 1999-04-01 2011-11-28 Dsm Ip Assets B.V. Aglomerados obtenidos por cristalización.
US6627556B1 (en) * 2002-04-24 2003-09-30 Lsi Logic Corporation Method of chemically altering a silicon surface and associated electrical devices
CN102268023B (zh) * 2011-08-15 2013-04-17 南京丰融化学技术有限公司 头孢类衍生物cxd的晶型
CN115160097B (zh) * 2022-07-22 2024-05-28 温州大学 一种硫代乙酸还原n-o键合成酰胺的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1308822A (en) * 1970-04-14 1973-03-07 Beecham Group Ltd 4-isopropylidene-3-oxocephams
GB1348985A (en) * 1970-06-16 1974-03-27 Merck & Co Inc Esters of cephalosporin compounds
IL37879A (en) * 1970-10-27 1974-12-31 Ciba Geigy Ag 3-unsubstituted cephalosporin derivatives,process for their manufacture and compositions containing them
US3704297A (en) * 1971-03-05 1972-11-28 American Home Prod 7 - (1,4 - cyclohexadienylacylamido)cephalosporanic acids and related compounds
US3741962A (en) * 1971-05-21 1973-06-26 Squibb & Sons Inc Alpha-thioureidocephalosporanic acid compounds
US3846417A (en) * 1972-06-23 1974-11-05 Squibb & Sons Inc 1,4-cyclohexadienyl imidazolidinyl cephalosporanic acids and derivatives thereof
US3917587A (en) * 1972-11-28 1975-11-04 Lilly Co Eli Cephalosporin ethers
US3917588A (en) * 1972-11-28 1975-11-04 Lilly Co Eli {60 -Aminoacyl cephalosporin ethers
US3907786A (en) * 1973-09-04 1975-09-23 Bristol Myers Co 7-{8 {60 -(2-aminomethyl-1,4-cyclohexadienyl)acetamido{9 -3-heterocyclic-thiomethyl-3-cephem-4-carboxylic acids and salts

Also Published As

Publication number Publication date
YU179273A (en) 1982-06-30
DD107470A5 (xx) 1974-08-05
AT356810B (de) 1980-05-27
AT329745B (de) 1976-05-25
NO145241B (no) 1981-11-02
ATA57675A (de) 1975-08-15
ATA569573A (de) 1975-06-15
LU67888A1 (xx) 1975-04-11
RO63761A (fr) 1978-12-15
GB1435111A (en) 1976-05-12
FI60870B (fi) 1981-12-31
FI59602C (fi) 1981-09-10
DD106184A5 (xx) 1974-06-05
JPS4949987A (xx) 1974-05-15
DE2331133A1 (de) 1974-01-17
LU67891A1 (xx) 1975-04-11
AR212576A1 (es) 1978-08-15
FR2190418B1 (xx) 1977-07-15
IL42506A0 (en) 1973-08-29
DD106187A5 (xx) 1974-06-05
JPS5933599B2 (ja) 1984-08-16
PL91608B1 (en) 1977-03-31
AR211871A1 (es) 1978-03-31
NL7309136A (xx) 1974-01-02
JPS5934716B2 (ja) 1984-08-24
ATA569473A (de) 1975-04-15
YU39911B (en) 1985-06-30
PH18567A (en) 1985-08-12
NO145242C (no) 1982-02-10
ATA569673A (de) 1975-08-15
AR211870A1 (es) 1978-03-31
DK153324B (da) 1988-07-04
HU169032B (xx) 1976-09-28
FI59601B (fi) 1981-05-29
YU179373A (en) 1982-06-30
YU223881A (en) 1983-06-30
HU168017B (xx) 1976-02-28
SE7308234L (sv) 1973-12-31
YU284280A (en) 1983-01-21
JPS5933598B2 (ja) 1984-08-16
FI59602B (fi) 1981-05-29
AT329762B (de) 1976-05-25
IE37767B1 (en) 1977-10-12
JPS4949988A (xx) 1974-05-15
AR212028A1 (es) 1978-04-28
YU39910B (en) 1985-06-30
RO64419A (fr) 1979-07-15
IE37767L (en) 1973-12-29
NO145241C (no) 1982-02-10
DE2331133C2 (de) 1984-04-12
NO145242B (no) 1981-11-02
YU223781A (en) 1983-06-30
AR206201A1 (es) 1976-07-07
SE7308237L (xx) 1974-01-08
RO64226A (fr) 1979-05-15
SE7308235L (xx) 1973-12-31
SE417430B (sv) 1981-03-16
FR2190418A1 (xx) 1974-02-01
IL42506A (en) 1976-09-30
SE7612053L (sv) 1976-10-29
YU179573A (en) 1982-06-30
AT356809B (de) 1980-05-27
CA1110230A (en) 1981-10-06
SE417099B (sv) 1981-02-23
BG24954A3 (en) 1978-06-15
NL7309137A (xx) 1974-01-02
SE417429B (sv) 1981-03-16
SE416812B (sv) 1981-02-09
YU39909B (en) 1985-06-30
BE801597A (fr) 1973-12-28
NO145240B (no) 1981-11-02
US4073902A (en) 1978-02-14
LU67887A1 (xx) 1975-04-11
HK73778A (en) 1978-12-22
YU223681A (en) 1983-06-30
AU5738673A (en) 1975-01-09
YU280780A (en) 1983-02-28
AR212317A1 (es) 1978-06-30
MY7900008A (en) 1979-12-31
SE7308233L (xx) 1973-12-31
NO145240C (no) 1982-02-10
RO73345A (ro) 1982-09-09
NL7309139A (xx) 1974-01-02
US4405778A (en) 1983-09-20
JPS4949986A (xx) 1974-05-15
FI59601C (fi) 1981-09-10
SE435289B (sv) 1984-09-17
HU167726B (xx) 1975-12-25

Similar Documents

Publication Publication Date Title
FI60870C (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla o-substituerade 7beta-amino-3-cefem-3-ol-4-karbonsyrafoereningar
EP0136721B1 (en) Carboxyalkenamidocephalosporins
US4201782A (en) Thiadiazolyl cephalosporin analogs
FI66389B (fi) Foerfarande foer framstaellning av 7beta-amino-2- eller -3-cefem-3-ol-4-karboxylsyrafoereningar
US4065620A (en) 3-(Substituted) vinyl cephalosporins
DK147683B (da) Analogifremgangsmaade til fremstilling af cephalosporinforbindelser eller ugiftige salte, biologisk acceptable estere, 1-oxyder eller solvater deraf
JPS6145627B2 (xx)
JPS5934714B2 (ja) 7β−アミノ−セフアム−3−オル−4−カルボン酸化合物または相当する3−θ−エステルの製法
US3983113A (en) Cephalosporin type antibacterials
Kukolja et al. Orally absorbable cephalosporin antibiotics. 1. Structure-activity relationships of benzothienyl-and naphthylglycine derivatives of 7-aminodeacetoxycephalosporanic acid
Crowell et al. 3-Sulfonyl-1-carba-1-dethiacephems
FI64599C (fi) Foerfarande foer framstaellning av som laekemedel anvaendbara 7-(d-alfa-fenyl-n-substituerade karbonyl-glycylamino)-3-(1-metyl-1h-tetrazol-5-yltiometyl)-oxadetia-3-cefem-4-karbonsyoroch natriumsalter daerav
FI66619B (fi) Foerfarande foer framstaellning av farceutiskt anvaendbara 7beta-(d-2-amino-2-(laogalkylsulfonylaminofenyl)-asetylamino)-3-r-3-cefem-4-karboxylsyror
JPS6124398B2 (xx)
JPS6019916B2 (ja) 0−置換された7β−アミノ−3−セフエム−3−オ−ル−4−カルボン酸化合物の製法
KR870002181B1 (ko) 세팔로스포린의 제조방법
PL90346B1 (xx)
US4252974A (en) Cephalosporin compounds
FI70901C (fi) Foerfarande foer framstaellning av 7beta-(5-oxo-4-fenylimidazolidin-1-yl)-3-klor-3-cefem-4-karboxylsyror
FI64941C (fi) 0-substituerade 7beta-amino-3-cefem-3-ol-4-karboxylsyrafoereningar
JPS61165366A (ja) ラクタム化合物の製造方法
CS199670B2 (cs) Způsob výroby derivátů 7/3-(p-hydroxyfenylmalonamido)-3-subst.thiomethyl-l-oxadethia-3-cefem-4-karboxylových kyselin
JPS5965095A (ja) 抗菌性化合物およびその製造方法
CS199669B2 (en) Method of producing derivatives of 7 beta-aryl-malonamido-3-substituted thiomethyl-1-oxadethia-3-cephem-4-carboxylic acids
CH609987A5 (en) Process for the preparation of N- and O-substituted 7 beta -aminocephem-3-ol-4-carboxylic acid compounds